RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational Research
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational Research
Authors
Keywords
Translational, Brain, Stroke, Hemorrhage, SAH, ICH, Clinical Trial, NIHSS, STAIR, STEPS, RIGOR
Journal
Translational Stroke Research
Volume 4, Issue 3, Pages 279-285
Publisher
Springer Nature
Online
2012-09-04
DOI
10.1007/s12975-012-0209-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke
- (2012) Denise M. Boudreau et al. ANNALS OF EMERGENCY MEDICINE
- Implementación de las guías de práctica clínica sobre ictus isquémico agudo en atención especializada
- (2012) A.J. Pardo Cabello et al. NEUROLOGIA
- Nonhuman Primate Models of Stroke for Translational Neuroprotection Research
- (2012) Douglas J. Cook et al. Neurotherapeutics
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
- (2011) Carol Kilkenny et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II
- (2011) Sean I. Savitz et al. STROKE
- Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies
- (2011) Gregory W. Albers et al. STROKE
- Effect of Antihypertensive Therapy on Incident Stroke in Cohorts With Prehypertensive Blood Pressure Levels
- (2011) Ilke Sipahi et al. STROKE
- Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?
- (2011) Renée J. Turner et al. Translational Stroke Research
- Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims
- (2011) Paul A. Lapchak Translational Stroke Research
- Executive Summary: Heart Disease and Stroke Statistics—2010 Update
- (2010) et al. CIRCULATION
- Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective
- (2010) Paul A Lapchak EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Trends in thrombolytic use for ischemic stroke in the United States
- (2010) Margaret C. Fang et al. Journal of Hospital Medicine
- The Science of Stroke: Mechanisms in Search of Treatments
- (2010) Michael A. Moskowitz et al. NEURON
- Translational Stroke Research Using a Rabbit Embolic Stroke Model: A Correlative Analysis Hypothesis for Novel Therapy Development
- (2010) Paul A. Lapchak Translational Stroke Research
- Effects of NXY-059 in experimental stroke: an individual animal meta-analysis
- (2009) PMW Bath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Heart Disease and Stroke Statistics—2009 Update
- (2009) et al. CIRCULATION
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
- (2009) Carol Kilkenny et al. PLoS One
- Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke
- (2009) Maarten G. Lansberg et al. STROKE
- Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
- (2009) Jeffrey L. Saver et al. STROKE
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
- (2008) Werner Hacke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Status of Neuroprotection for Cerebral Ischemia: Synoptic Overview
- (2008) M. D. Ginsberg STROKE
- Cosmic Implications of NXY-059
- (2008) S. I. Savitz STROKE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started